News briefing: Novo eyes the next kinases in a Finnish startup; Boehringer Ingelheim brings a bispecific to the clinic
Novo Seeds’ Jeroen Bakker thinks he’s found the next kinases.
The early stage, European VC firm announced yesterday they led a $9 million seed round …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
